The following labs are interested in virology:
|James Alwine||HCMV; SV40; viral transactivators; tumor virology; RNA processing; metabolism|
|Paul Bates|| Ebola, Virus entry, glycoproteins, viral assembly, SARS, retrovirus, gene therapy
|Jeffrey Bergelson||Virus entry, adenovirus, coxsackievirus, viral pathogenesis, virus receptor|
|Michael Betts||HIV; T cell; Immune Response|
|Frederic Bushman||HIV, integration, integrase, poxvirus, DNA modifying enzyme, virology, variola, RNA interference, interferon|
|Kyong-Mi Chang||HCV, HBV, liver disease, HIV/HCV coinfection, alcohol, viral pathogenesis, viral persistence, immune regulation, T cell exhaustion, transplant tolerance, epitope mapping, immunogenetics|
|Sara Cherry||Virus, genomics, RNAi, genetics, Drosophila, innate, immunity
|Gary Cohen||Herpes, HSV, virology, glycoproteins, virus entry|
|Ronald Collman||HIV, virus, tropism, signal transduction, gp120, viral envelope, macrophage|
|Gudrun Debes||Effector and memory lymphocytes, unlike naïve lymphocytes, can efficiently enter extralymphoid tissues as well as sites of inflammation and infection. Subsequently, lymphocytes enter the afferent lymph to reach draining lymph nodes. After a short time period of residency, lymphocytes exit the lymph node via the efferent lymph, which brings them back into the blood. This dynamic process of lymphocyte recirculation, which is tightly regulated at each step, is essential for immune surveillance and efficient defense against pathogens, but it can also contribute to the development of inflammatory diseases.|
|Robert Doms||HIV, Rift Valley fever virus, Virus-host cell interactions, Andes virus|
|Roselyn Eisenberg||Herpes, HSV, virology, glycoproteins, virus entry|
|Laurence Eisenlohr||Cell biology of MHC class I-restricted antigen processing and presentation, MHD class II-restricted antigen processing and presentation, "Cryptic" MHC Class I-Restricted Epitopes, Cancer immunotherapy and autoimmunity|
|Nigel Fraser||Herpes Simplex Virus, viral latency, Gene transfer to neurons, oncolytic virus cancer therapy|
|Harvey Friedman||HSV immune evasion, glycoprotein gC, glycoprotein gE, complement, pathogenesis|
|Glen Gaulton|| Lymphocyte Development, Retrovirus Pathology, HIV-1, Imaging, Diagnostics
|Beatrice Hahn||HIV-1 transmission, ape Plasmodium infections, SIVcpz infection of wild chimpanzee, HIV vaccine development|
|Ronald Harty|| Ebola virus; VSV; Matrix Proteins; Budding; Reverse-Genetics; Virus-Host Interactions.
|Scott Hensley|| Influenza virus, antigenic drift, viral pathogenesis, viral receptors, antibody specificity, vaccines
|James Hoxie||AIDS, CD4, chemokine receptors, HIV, SIV, envelope glycoproteins, viral entry, neutralization, vaccine|
|Stuart Isaacs|| Vaccinia virus, Recombinant vaccines, poxvirus , pathogenesis, smallpox, smallpox therapeutics.
|Kelly Jordan-Sciutto||Cell Cycle, Oxidative Stress Response, Antioxidant Response, Neurodegeneration, Transcription, Primary Culture, HIV encephalitis, Alzheimer Disease, Parkinson disease, Retinoblastoma, E2F1|
|Rahul Kohli||Our laboratory focuses on the enzymatic generation of genomic diversity. We utilize a broad array of approaches, including biochemical characterization of enzyme mechanisms, chemical synthesis of enzyme probes, and biological assays spanning immunology and virology to study this central tactic in the constant battle between our immune system and pathogens.|
|Dennis Kolson||Neuron, hippocampus, apoptosis, gene expression, single-cell mRNA, HIV, chemokine receptor, NMDA receptor.|
|Paul Lieberman||Viral latency, telomeres, chromatin, DNA replication, transcription regulation, herpesvirus.|
|Carolina Lopez|| Virus-host interaction, innate immunity, respiratory viruses, lung immunity.
|Luis Montaner||Innate Immunity & HIV-1 Infection: Dendritic cells & Natural Killer Cells Direct or indirect interactions of viral particles with innate and specific adaptive immunity effector cells affects the cross talk between antigen presenting cells (APCs), NK cells and the antigen specific T and B-lymphocytes, and may contribute to regulate HIV disease progression. Specifically, we are pursuing analysis of the effects of HIV infection in macrophages, dendritic cells and Natural Killer cells|
|Una O'Doherty|| HIV, latency, reservoirs, dendritic cells, viral pathogenesis, proviral integration, retrovirus, virology, T cell activation, resting T cells.
|Yvonne Paterson||Immune regulation, antigen design, vaccine development, cancer immunotherapy, HIV, HPV|
|Glenn Rall|| measles, neuron, CNS, immunology.
|Robert Ricciardi|| Our laboratory is interested in the mechanisms by which oncogenic proteins of human viruses exploit cellular functions and regulate gene expression to produce disease and cancer.
|James Riley|| T cell activation, Tumor Specific T cells, HIV specific T cells, expression profiles.
|Erle Robertson||oncogenesis, viruses and cancer, viral oncology, Tumor Virology, Gene therapy, Kaposi's Sarcoma, Epstein-Barr Virus, Lymphoproliferative disease, Lymphomas.|
|George Shaw||Molecular studies of HIV-1 transmission, persistence and pathogenesis, SIV transmission, persistence and pathogenesis, HCV transmission, persistence and pathogenesis|
|David Weiner||DNA Vaccines, HIV, Viral Protein R., Vaccines.|
|Susan Weiss||Murine coronavirus, SARS associated coronavirus, viral pathogenesis.|
|Drew Weissman||HIV, Immunopathogenesis, RNAi, DMBT1, dendritic cell, siRNA, antigen presentation.|
|Matthew D. Weitzman||Virology, Virus Replication, DNA Damage and Repair, Genome Instability, Viral Vectors|
|E. John Wherry|| Immunological memory, T cell memory, Chronic infection, T cell dysfunction, Memory T cell differentiation.
|James Wilson||Adenovirus, adeno-associated virus (AAV), gene therapy, gene transfer, lentivirus.|
|Jianxin You|| DNA tumor viruses, Host targets, Persistent latent infection, Episome maintenance, Oncogenesis, Tumor virology, Gene therapy,
|Yan Yuan|| Kaposi's sarcoma-associated herpesvirus, virus-host interaction, microRNAs.